The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes of immune checkpoint inhibitor-mediated colitis: Multicenter cohort study.
 
Hamzah Abu-Sbeih
No Relationships to Disclose
 
Tenglong Tang
No Relationships to Disclose
 
David M. Faleck
Honoraria - TotalCME
Consulting or Advisory Role - Kaleido Biosciences
 
Michael L. Dougan
Leadership - Neoleukin Therapeutics
Stock and Other Ownership Interests - Johnson & Johnson; Pfizer
Consulting or Advisory Role - Genentech/Roche; ORIC Pharmaceuticals; ORIC Pharmaceuticals; Partners Therapeutics; Tillotts Pharma
Research Funding - Novartis
 
Anna Olsson-Brown
No Relationships to Disclose
 
Douglas Buckner Johnson
Consulting or Advisory Role - Bristol-Myers Squibb; Catalyst Pharmaceuticals; Iovance Biotherapeutics; Janssen; Merck; Novartis; Oncosec
Research Funding - Bristol-Myers Squibb; Incyte
Patents, Royalties, Other Intellectual Property - Intellectual property and patents pending surrounding use of MHC-II and response to immune therapy
 
Dwight Hall Owen
Consulting or Advisory Role - theMednet
Research Funding - Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Merck Sharp & Dohme (Inst); Onc.AI (Inst); Palobiofarma (Inst)
 
David Engar Warner
No Relationships to Disclose
 
Alexander B Philipp
No Relationships to Disclose
 
Nick Powell
No Relationships to Disclose
 
Ella Daniels
No Relationships to Disclose
 
Jessica Philpott
No Relationships to Disclose
 
Alison Margaret Weppler
No Relationships to Disclose
 
David James Pinato
Honoraria - Bristol-Myers Squibb; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Da Volterra; Eisai; H3 Biomedicine; Mina Therapeutics; Roche
Speakers' Bureau - Bayer; Falk Pharma; Roche; ViiV Healthcare
Research Funding - Bristol-Myers Squibb; GlaxoSmithKline (Inst); MSD Oncology
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; MSD Oncology
 
Yinghong Wang
Consulting or Advisory Role - Tillotts Pharma